Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins

Journal of Proteome Research

Volumn 9, Issue 3, 2010, Pages 1236-1245

  Drabovich, Andrei P ^a   Diamandis, Eleftherios P ^a,b,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Ascites; Combinatorial peptide libraries; Low abundance proteins; Mass spectrometry; Multiple reaction monitoring; Multiplexed assays; Ovarian cancer

Indexed keywords

FOLLISTATIN RELATED PROTEIN; KALLIKREIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; MESOTHELIN; METALLOPROTEINASE INHIBITOR; PEPTIDE LIBRARY;

ARTICLE; ASCITES; ASCITES FLUID; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; TANDEM MASS SPECTROMETRY;

ASCITES; COMBINATORIAL CHEMISTRY TECHNIQUES; FEMALE; HUMANS; KALLIKREINS; LINEAR MODELS; OVARIAN NEOPLASMS; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 77949822351     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr900729g     Document Type: Article

References (38)

1. Hanash, S. M.; Pitteri, S. J.; Faca, V. M. Mining the plasma proteome for cancer biomarkers. Nature 2008, 452 (7187), 571-579
2. Edwards, A. V.; White, M. Y.; Cordwell, S. J. The role of proteomics In clinical cardiovascular blomarker discovery. Mol. Cell. Proteomica 2008, 7 (10), 1824-1837
3. Ekegren, T.; Hanrieder, J.; Bergquist, J. Clinical perspectives of highresolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research, J. Mass Spectrom. 2008, 43 (5), 559-571
4. Collins, B. C.; Clarke, A.; Kitteringham, N. R.; Gallagher, W. M.; Pennington, S. R. Use of proteomics for the discovery of early markers of drug toxicity. Expert Opin. Drug Metab. Toxicol. 2007, 3 (5), 689-704.
5. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58 (2), 71-96.
6. Jacobs, I.; Bast, R. C., Jr. The CA 125 tumour-associated antigen: a review of the literature. Hum. Reprod. 1989, 4 (1), 1-12.
7. Gargano, G.; Correale, M.; Abbate, I.; Falco, G.; De Frenza, N.; Lorusso, V.; De Lena, M.; De Leonardis, A The role of tumour markers in ovarian cancer. Clin. Exp. Obstet. Gynecol. 1990, 17 (1), 23-29
8. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2007, 6 (12), 2212-2229
9. Tamsma, J. T.; Keizer, H. J.; Meinders, A. E. Pathogenesis of malignant ascites: Starling's law of capillary hemodynamics revisited. Ann. Oncol. 2001, 12 (10), 1353-1357
10. Kuk, C.; Kulasingam, V.; Gunawardana, C. G.; Smith, C. R.; Batruch, I.; Diamandis, E. P. Mining the ovarian cancer ascites proteome for potential ovarian cancer biomarkers. Mol. Cell. Proteomics 2009, 8 (4), 661-669
11. Gortzak-Uzan, L.; Ignatchenko, A.; Evangelou, A. I.; Agochiya, M.; Brown, K. A.; St Onge, P.; Kireeva, I.; Schmitt-Ulms, G.; Brown, T. J.; Murphy, J.; Rosen, B.; Shaw, P.; Jurisica, I.; Kislinger, T. A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. J. Proteome Res. 2008, 7 (1), 339-351
12. Kulasingam, V.; Diamandis, E. P. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat. Clin. Pract. Oncol. 2008, 5 (10), 588-599
13. Boschetti, E.; Righetti, P. G. The art of observing rare protein species in proteomes with peptide ligand libraries. Proteomics 2009, 9 (6), 1492-1510
14. Boschetti, E.; Lomas, L.; Citterio, A.; Righettl, P. G. Romancing the "hidden proteome", Anno Domini two zero zero seven. J. Chromatoger., 2007, 1153 (1-2), 277-290
15. Kersey, P. J.; Duarte, J.; Williams, A.; Karavidopoulou, Y.; Birney, E.; Apweiler, R. The International Protein Index: an integrated database for proteomics experiments. Proteomics 2004, 4 (7), 1985-1988
16. Diamandis, E. P.; Yousef, G. M.; Soosaipillai, A. R.; Grass, L.; Porter, A; Little, S.; Sotiropoulou, G. Immunofluorometric assay of human kallikrein 6 (zyme/protease M/neurosin) and preliminary clinical applications, Clin. Biochem. 2000, 33 (5), 369-375
17. Luo, L. Y.; Soosaipillai, A.; Grass, L.; Diamandis, E. P. Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients. Turnar Biol. 2006, 27 (5), 227-234
18. Hortin, G. L.; Sviridov, D.; Anderson, N. L. High-abundance polypeptides of the human plasma proteome comprising the top 4 logs of polypeptide abundance. Clin. Chem. 2008, 54 (10), 1608-1616
19. Prakash, A.; Tomazela, D. M.; Frewen, B.; Maclean, B.; Merrihew, G.; Peterman, S.; Maccoss, M. J. Expediting the development of targeted SRM assays: using data from shotgun proteomics to automate method development. J. Proteome Res. 2009, 8 (6), 2733-2739
20. Kuzyk, M. A; Smith, D.; Yang, J.; Cross, T. J.; Jackson, A M.; Hardie, D. B.; Anderson, N. L.; Borchers, C. H. MRM-based, multiplexed, absolute quantitation of 45 proteins in human plasma. Mol. Cell. Proteomics 2009, 8 (8), 1860-1877
21. Polanski, M.; Anderson, L. N. A List of Candidate Cancer Biomarkers for Targeted Proteomics. Biomarker Insights 2006, 2, 1-48.
22. Kobel, M.; Kalloger, S. E.; Boyd, N.; McKinney, S.; Mehl, E.; Palmer, C.; Leung, S.; Bowen, N. J.; Ionescu, D. N.; Rajput, A.; Prentice, L. M.; Miller, D.; Santos, J.; Swenerton, K.; Gilks, C. B.; Huntsman, D. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2008, 5 (12), e232.
23. Diamandis, E. P.; Scorilas, A; Fracchioli, S.; Van Gramberen, M.; De Bruijn, H.; Henrik, A.; Soosaipillai, A.; Grass, L.; Yousef, G. M.; Stenman, U. H.; Massobrio, M.; Van Der Zee, A. G.; Vergote, I.; Katsaros, D. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J. Clin. Oncol. 2003, 21 (6), 1035-1043
24. Dudley, J. T.; Butte, A. J. Identification of discriminating biomarkers for human disease using integrative network biology. Pac. Symp. Biocomput. 2009, 27-38.
25. Zhang, S.; Zhang, X. S.; Chen, L. Biomolecular network querying: a promising approach in systems biology. BMC Syst. 2008, 2, 5.
26. Adourian, A.; Jennings, E.; Balasubramanian, R.; Hines, W. M.; Damian, D.; Plasterer, T. N.; Clish, C. B.; Stroobant, P.; McBurney, R.; Verheij, E. R.; Bobeldijk, I.; van der Greef, J.; Lindberg, J.; Kenne, K.; Andersson, U.; Hellmold, H.; Nilsson, K.; Salter, H.; SchuppeKoistinen, I. Correlation network analysis for data integration and biomarker selection. Mol. BioSyst. 2008, 4 (3), 249-259
27. Qian, W. J.; Kaleta, D. T.; Petrltls, B. O.; Jiang, H.; Liu, T.; Zhang, X.; Mottaz, H. M.; Varnum, S. M.; Camp, D. G., 2nd; Huang, L.; Fang, X.; Zhang, W. W.; Smith, R. D. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol. Cell. Proteomics 2008, 7 (10), 1963-1973
28. Pernemalm, M.; Lewensohn, R.; Lehtio, J. Affinity prefractionation for MS-based plasma proteomics. Proteomics 2009, 9 (6), 1420-1427
29. Zolotarjova, N.; Martosella, J.; Nicol, G.; Bailey, J.; Boyes, B. E.; Barrett, W. C. Differences among techniques for high-abundant protein depletion. Proteomics 2005, 5 (13), 3304-3313
30. Ichibangase, T.; Moriya, K.; Koike, K.; Imai, K. Limitation of immunoaffinity column for the removal of abundant proteins from plasma in quantitative plasma proteomics. Biomed. Chromatogr. 2009, 23 (5), 480-487
31. Hammond, D. J.; Lathrop, J. T., Identification and characterization of analytes from whole blood. US Patent Application 11/454, 801, 2007.
32. Roux-Dalvai, F.; Gonzalez de Peredo, A.; Simo, C.; Guerrier, L.; Bouyssie, D.; Zanella, A.; Citterio, A.; Burlet-Schlitz, O.; Boschetti, E.; Righetti, P. G.; Monsarrat, B. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol. Cell. Proteomics 2008, 7 (11), 2254-2269
33. Kuhn, E.; Addona, T.; Keshishian, H.; Burgess, M.; Mani, D. R.; Lee, R. T.; Sabatine, M. S.; Gerszten, R. E.; Carr, S. A. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin. Chem. 2009, 55 (6), 1108-1117
34. Wang, K. Y.; Chuang, S. A.; Lin, P. C.; Huang, L. S.; Chen, S. H.; Ouarda, S.; Pan, W. H.; Lee, P. Y.; Lin, C. C.; Chen, Y. J. Multiplexed immunoassay: quantitation and profiling of serum biomarkers using magnetic nanoprobes and MALDI-TOF MS. Anal. Chem. 2008, 80 (16), 6159-6167
35. Pringle, S. D.; Giles, K.; Wildgoose, J. L.; Williams, J. P.; Slade, S. E.; Thalasslnos, K.; Bateman, R. H.; Bowers, M. T.; Scrivens, J. H. An investigation of the mobility separation of some peptide and protein ions using a new hybrid quadrupole/travelling wave IMS/ oa-ToF instrument. Int. J. Mass Spectrom. 2007, 267 (1), 1-12.
36. Bachl, A.; Bonaldi, T. Quantitative proteomics as a new piece of the systems biology puzzle. J. Proteomics 2008, 71 (3), 357-367
37. Feng, X.; Liu, X.; Luo, Q.; Liu, B. F. Mass spectrometry in systems biology an overview. Mass Spectrom. Rev. 2008, 27 (6), 635-660
38. Rho, S.; You, S.; Kim, Y.; Hwang, D. From proteomics toward systems biology integration of different types of proteomics data into network models. BMB Rep. 2008, 41 (3), 184-193